Hepatic decompensation/serious adverse events in post-liver transplantation recipients on sofosbuvir for recurrent hepatitis C virus

AIM: To determine the safety profile of new hepatitis C virus (HCV) treatments in liver transplant (LT) recipients with recurrent HCV infection. METHODS: Forty-two patients were identified with recurrent HCV infection that underwent LT at least 12 mo prior to initiating treatment with a Sofosbuvir-b...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:World J Gastroenterol
Autores principales: Patel, Neal, Bichoupan, Kian, Ku, Lawrence, Yalamanchili, Rachana, Harty, Alyson, Gardenier, Donald, Ng, Michel, Motamed, David, Khaitova, Viktoriya, Bach, Nancy, Chang, Charissa, Grewal, Priya, Bansal, Meena, Agarwal, Ritu, Liu, Lawrence, Im, Gene, Leong, Jennifer, Kim-Schluger, Leona, Odin, Joseph, Ahmad, Jawad, Friedman, Scott, Dieterich, Douglas, Schiano, Thomas, Perumalswami, Ponni, Branch, Andrea
Formato: Artigo
Lenguaje:Inglês
Publicado: Baishideng Publishing Group Inc 2016
Materias:
Observational Study
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4778007/
https://ncbi.nlm.nih.gov/pubmed/26973423
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v22.i9.2844
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares